212 related articles for article (PubMed ID: 34978120)
1. Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune function.
Tian H; Wang G; Wang Q; Zhang B; Jiang G; Li H; Chai D; Fang L; Wang M; Zheng J
Cancer Sci; 2022 Mar; 113(3):875-890. PubMed ID: 34978120
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness.
Tian H; Chai D; Wang G; Wang Q; Sun N; Jiang G; Li H; Song J; Fang L; Wang M; Guo Z; Zheng J
Cancer Immunol Immunother; 2023 Jul; 72(7):2151-2168. PubMed ID: 36828964
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death.
McGee AM; Douglas DL; Liang Y; Hyder SM; Baines CP
Cell Cycle; 2011 Dec; 10(23):4119-27. PubMed ID: 22101277
[TBL] [Abstract][Full Text] [Related]
4. C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response.
Wang Q; Chai D; Sobhani N; Sun N; Neeli P; Zheng J; Tian H
Front Physiol; 2022; 13():1012112. PubMed ID: 36467687
[TBL] [Abstract][Full Text] [Related]
5. GSNOR overexpression enhances CAR-T cell stemness and anti-tumor function by enforcing mitochondrial fitness.
Niu Q; Zhang H; Wang F; Xu X; Luo Y; He B; Shi M; Jiang E; Feng X
Mol Ther; 2024 Jun; 32(6):1875-1894. PubMed ID: 38549378
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis.
Zhang C; Liu Y; Jiang J; Chen C; Duan Z; Su H; Wang S; Tian B; Shi Y; Xiang R; Luo Y
Theranostics; 2024; 14(7):2757-2776. PubMed ID: 38773982
[No Abstract] [Full Text] [Related]
7. Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways.
Liu YN; Yang JF; Huang DJ; Ni HH; Zhang CX; Zhang L; He J; Gu JM; Chen HX; Mai HQ; Chen QY; Zhang XS; Gao S; Li J
Front Immunol; 2020; 11():1906. PubMed ID: 32973789
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight fibroblast growth factor 2 induces apoptosis by interacting with complement component 1 Q subcomponent-binding protein in vitro.
Hong X; Yu Z; Chen Z; Jiang H; Niu Y; Huang Z
J Cell Biochem; 2018 Nov; 119(11):8807-8817. PubMed ID: 30159917
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
10. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
11. C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation.
Wang Y; Liu S; Tian S; Du R; Lin T; Xiao X; Wang R; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
Int J Med Sci; 2022; 19(5):842-857. PubMed ID: 35693733
[No Abstract] [Full Text] [Related]
12. Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathway.
Wu CS; Chen GS; Lin PY; Pan IH; Wang ST; Lin SH; Yu HS; Lin CC
DNA Cell Biol; 2014 Oct; 33(10):652-66. PubMed ID: 24927175
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 is a master regulator of memory programming in CAR T cells.
Doan AE; Mueller KP; Chen AY; Rouin GT; Chen Y; Daniel B; Lattin J; Markovska M; Mozarsky B; Arias-Umana J; Hapke R; Jung IY; Wang A; Xu P; Klysz D; Zuern G; Bashti M; Quinn PJ; Miao Z; Sandor K; Zhang W; Chen GM; Ryu F; Logun M; Hall J; Tan K; Grupp SA; McClory SE; Lareau CA; Fraietta JA; Sotillo E; Satpathy AT; Mackall CL; Weber EW
Nature; 2024 May; 629(8010):211-218. PubMed ID: 38600391
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963
[TBL] [Abstract][Full Text] [Related]
15. PSAP induces a unique Apaf-1 and Smac-dependent mitochondrial apoptotic pathway independent of Bcl-2 family proteins.
Li T; Zeng L; Gao W; Cui MZ; Fu X; Xu X
Biochim Biophys Acta; 2013 Mar; 1832(3):453-74. PubMed ID: 23207240
[TBL] [Abstract][Full Text] [Related]
16. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway.
Zheng QY; Cao ZH; Hu XB; Li GQ; Dong SF; Xu GL; Zhang KQ
J Cell Mol Med; 2016 Oct; 20(10):1861-71. PubMed ID: 27241100
[TBL] [Abstract][Full Text] [Related]
17. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
[TBL] [Abstract][Full Text] [Related]
19. T-cell death following immune activation is mediated by mitochondria-localized SARM.
Panneerselvam P; Singh LP; Selvarajan V; Chng WJ; Ng SB; Tan NS; Ho B; Chen J; Ding JL
Cell Death Differ; 2013 Mar; 20(3):478-89. PubMed ID: 23175186
[TBL] [Abstract][Full Text] [Related]
20. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death.
McGee AM; Baines CP
Biochem J; 2011 Jan; 433(1):119-25. PubMed ID: 20950273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
